Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Stockholders' equity
Noncontrolling interests
Total
Balance at Dec. 31, 2019 $ 3 $ 44,853 $ (7,891) $ (2,651) $ 33,912 $ (402) $ 34,314
Balance (in shares) at Dec. 31, 2019 28,603,829            
Stock-based compensation   338     338   338
Stock-based compensation, in shares 69,327            
Exercise of stock options   38     38   38
Exercise of stock options (in shares) 18,000            
Issuance of common shares, net of tax withholding (in shares) 116,644            
Loss on foreign currency translation, net       (44) (44)   (44)
Net income (loss)     (4,599)   (4,873) (274) (4,599)
Balance at Mar. 31, 2020 $ 3 45,229 (12,490) (2,695) 29,371 (676) 30,047
Balance (in shares) at Mar. 31, 2020 28,807,800            
Balance at Dec. 31, 2020 $ 3 46,538 (20,716) (2,646) 21,979 (1,200) 23,179
Balance (in shares) at Dec. 31, 2020 29,083,183            
Stock-based compensation   1,022     1,022   1,022
Stock-based compensation, in shares 25,643            
Exercise of warrants (in shares) 450,971            
Issuance of common shares, net of tax withholding   (154)     (154)   (154)
Issuance of common shares, net of tax withholding (in shares) 67,685            
Purchase of noncontrolling interest   116     (75) (191) 116
Loss on foreign currency translation, net       (18) (18)   (18)
Net income (loss)     70   (60) (130) 70
Balance at Mar. 31, 2021 $ 3 $ 47,522 $ (20,646) $ (2,664) $ 22,694 $ (1,521) $ 24,215
Balance (in shares) at Mar. 31, 2021 29,627,482